Surge in good news: AstraZeneca Covid vaccine 79% effective in U.S. trial
The safety and efficacy analysis of the vaccine was based on 32,449 participants in a phase 3 trial. Source: AstraZeneca Covid vaccine 79% effective in U.S. trial
Opinion: Practicing Factfulness based on data.
The safety and efficacy analysis of the vaccine was based on 32,449 participants in a phase 3 trial. Source: AstraZeneca Covid vaccine 79% effective in U.S. trial
In 2020, I saw one public health officer say the Constitution may be suspended during a pandemic. Unfortunately, I did not save that at the time. (If you are wondering,…
Jan 11-12, 2021: Thousands of University of Alabama football fans partied in the street near campus after the Crimson Tide defeated Ohio State 52-24 for the national championship, ignoring pleas…
When middle and high school students go back to campus, they’ll have the option to wear a lanyard that keeps track of social distancing, alerting students when they get too…
Meanwhile, back in lock down havens schools remain mostly closed … because epi-astrology! Schools in the state have avoided major outbreaks of Covid-19 and maintained case rates lower than those…
Interesting to see early reviews of this era. And none of them are particularly nice. Francois Balloux, an infectious-disease epidemiologist and computational geneticist at the University College of London, goes…
More media is noticing that public health this past year was quackery disconnected from the reality: For too long, America has approached public health issues with puritanical, black-and-white approaches. Whether…
The reasons for spelling “vaccine” as “vacksine” is to slide past the Twitter auto-censor bots. This finding is interesting and unfortunate. Some more background here.
Thousands of pupils and their families are having to isolate needlessly, and missing more days after months away from classrooms Source: Seven in 10 positive Covid cases in school children…
Novavax Inc’s COVID-19 vaccine was 96% effective in preventing cases caused by the original version of the coronavirus in a late-stage trial conducted in the United Kingdom, the company said…